Desvenlafaxine Succinate
(ORUUBRMVQCKYHB-UHFFFAOYSA-N)
Structure
- SMILES
- CN(CC(C1(O)CCCCC1)c1ccc(cc1)O)C.OC(=O)CCC(=O)O
- Molecular Formula:
- C20H31NO6
- Molecular Weight:
- 381.463
- Log P:
- 2.6684
- Hydrogen Bond Acceptor:
- 7
- Hydrogen Bond Donor:
- 4
- TPSA:
- 118.3
- CAS Number(s):
- 448904-47-0
Synonym(s)
1.
Desvenlafaxine Succinate
2.
2-(1-hydroxycyclohexyl)-2-((4-hydroxyphenyl)ethyl)dimethylammonium 3-carboxypropanoate monohydrate
3.
4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol
4.
Desvenlafaxine
5.
O-desmethylvenlafaxine
6.
O-desmethylvenlafaxine Succinate
7.
O-desmethylvenlafaxine Succinate Monohydrate
8.
Pristiq
9.
WY 45,233
10.
WY 45233
11.
WY-45,233
12.
WY-45233
13.
45,233, WY
14.
45233, WY
15.
Monohydrate, O-desmethylvenlafaxine Succinate
16.
O desmethylvenlafaxine
17.
O desmethylvenlafaxine Succinate
18.
O desmethylvenlafaxine Succinate Monohydrate
19.
Succinate Monohydrate, O-desmethylvenlafaxine
20.
Succinate, Desvenlafaxine
21.
Succinate, O-desmethylvenlafaxine
22.
WY45,233
23.
WY45233
External Link(s)
| MeSH | D000069468 |
| PubChem Compound | 9800068 |
| CHEMBL | CHEMBL1201728 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Product substitution issue | FAERS: 19 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | Drug ineffective | FAERS: 17 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 3 | Headache | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 4 | Nausea | FAERS: 6 Canada Vigilance: 2 | 24234943 | CTD Canada Vigilance US FAERS |
| 5 | Feeling abnormal | FAERS: 5 | US FAERS | |
| 6 | Crying | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Medication residue present | FAERS: 4 | US FAERS | |
| 8 | Anger | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 9 | Anxiety | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Depressed mood | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Drug withdrawal syndrome | FAERS: 2 | US FAERS | |
| 12 | Fatigue | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 13 | Malaise | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 14 | Unevaluable event | FAERS: 2 | US FAERS | |
| 15 | Acute kidney injury | FAERS: 1 | US FAERS | |
| 16 | Adverse event | FAERS: 1 | US FAERS | |
| 17 | Anuria | FAERS: 1 | US FAERS | |
| 18 | Apathy | FAERS: 1 | US FAERS | |
| 19 | Bedridden | FAERS: 1 | US FAERS | |
| 20 | Dizziness | FAERS: 1 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 21 | Drug effect variable | FAERS: 1 | US FAERS | |
| 22 | Dysarthria | FAERS: 1 | US FAERS | |
| 23 | Flank Pain | FAERS: 1 | US FAERS | |
| 24 | Head discomfort | FAERS: 1 | US FAERS | |
| 25 | Hypophagia | FAERS: 1 | US FAERS | |
| 26 | Impatience | FAERS: 1 | US FAERS | |
| 27 | Myositis | FAERS: 1 | US FAERS | |
| 28 | Nervousness | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 29 | Palpitations | FAERS: 1 | US FAERS | |
| 30 | Product dose omission | FAERS: 1 | US FAERS | |
| 31 | Product use complaint | FAERS: 1 | US FAERS | |
| 32 | Pruritus | FAERS: 1 | US FAERS | |
| 33 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 34 | Tachycardia | FAERS: 1 | US FAERS | |
| 35 | Tremor | FAERS: 1 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 36 | Agitation | Canada Vigilance: 1 | Canada Vigilance | |
| 37 | Angle Closure Glaucoma | Canada Vigilance: 1 | Canada Vigilance | |
| 38 | Anticholinergic Syndrome | Canada Vigilance: 1 | Canada Vigilance | |
| 39 | Anxiety Disorders | 24234943 | CTD | |
| 40 | Asthenia | Canada Vigilance: 1 | Canada Vigilance | |
| 41 | Atrial Fibrillation | Canada Vigilance: 1 | Canada Vigilance | |
| 42 | Burning sensation | Canada Vigilance: 1 | Canada Vigilance | |
| 43 | Cataract | Canada Vigilance: 1 | Canada Vigilance | |
| 44 | Chest Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 45 | Completed Suicide | Canada Vigilance: 1 | Canada Vigilance | |
| 46 | Confusion | 24234943 | CTD | |
| 47 | Drug Tolerance | Canada Vigilance: 1 | Canada Vigilance | |
| 48 | Drug ineffective for unapproved indication | Canada Vigilance: 1 | Canada Vigilance | |
| 49 | Dysphonia | Canada Vigilance: 1 | Canada Vigilance | |
| 50 | Feeling of body temperature change | Canada Vigilance: 1 | Canada Vigilance | |
| 51 | Flat affect | Canada Vigilance: 1 | Canada Vigilance | |
| 52 | Hyponatremia | 24234943 | CTD | |
| 53 | Intentional product misuse | Canada Vigilance: 1 | Canada Vigilance | |
| 54 | Mental disorders | 16856516 | CTD | |
| 55 | Nasopharyngitis | Canada Vigilance: 1 | Canada Vigilance | |
| 56 | Overdose | Canada Vigilance: 1 | Canada Vigilance | |
| 57 | Paranoia | Canada Vigilance: 1 | Canada Vigilance | |
| 58 | Poor quality sleep | Canada Vigilance: 1 | Canada Vigilance | |
| 59 | Product complaint | Canada Vigilance: 1 | Canada Vigilance | |
| 60 | Product prescribing error | Canada Vigilance: 1 | Canada Vigilance | |
| 61 | Product residue present | Canada Vigilance: 2 | Canada Vigilance | |
| 62 | Product use in unapproved indication | Canada Vigilance: 2 | Canada Vigilance | |
| 63 | Respiratory arrest | Canada Vigilance: 1 | Canada Vigilance | |
| 64 | Sexual Dysfunction | Canada Vigilance: 1 | Canada Vigilance | |
| 65 | Stevens-Johnson Syndrome | 25811541 | CTD | |
| 66 | Syncope | Canada Vigilance: 2 | Canada Vigilance | |
| 67 | Therapeutic product effect incomplete | Canada Vigilance: 3 | Canada Vigilance | |
| 68 | Tinnitus | Canada Vigilance: 2 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.